ub99 casino
Recent data from fDi Markets shows manufacturing foreign direct investment (FDI) into Asean now exceeds that going into China. This could be seen as evidence that Asean's gain is China's loss, as geopolitical tensions drive international businesses to diversify their supply chains. But this conclusion misses two facts. First, Chinese manufacturers are themselves expanding their presence in Southeast Asia. A third of the region's manufacturing FDI last year came from China, which was more than three times the amount from the US, Korea or Japan, according to fDi Markets. Second, what these headline numbers don't show is Chinese investment in Asean goes well beyond low-cost assembly to encompass advanced manufacturing, technology and even professional services. China isn't just the biggest source of FDI into Asean, its investment in the region is driven by Asean's broad fundamental strengths more than narrower ambitions to simply diversify supply chains or reduce the cost of production. We are seeing this trend among our own clients. At HSBC, our commercial banking activity for Chinese corporates doing business in Asean increased by around 60% in 2023 year-on-year. We also recorded an 80% increase in the number of Chinese corporates entering new Southeast Asian markets in 2023 versus 2022. Among our Chinese clients, we're seeing strong interest in expanding into Singapore, followed by Vietnam, Thailand, Malaysia and Indonesia. ASEAN'S APPEAL Chinese businesses are drawn to Asean primarily by growth opportunities -- and they are ahead of global peers in engaging with the region. A survey of 3,500 global businesses that we conducted last year found that its skilled workforce, growing digital economy, competitive wages and sizeable regional market were among Asean's top attractions. The study also found, compared with businesses from the US and Europe, a higher proportion of firms from mainland China and Hong Kong had already achieved organic growth in the region and were looking to increase mergers and acquisitions activity there. Asean, already China's largest trading partner, offers a wide range of growth opportunities to Chinese businesses, underpinned by its solid economic fundamentals, increasingly sophisticated manufacturing capabilities, supply chain and logistics efficiencies, cultural similarities and growing middle class. Electric vehicles are a case in point. China is the world's biggest EV producer and market. Leading Chinese EV makers are now becoming dominant in Southeast Asia, where they account for some 75% of all EV sales and brands including BYD, Geely and Great Wall Motor, which are scaling up their manufacturing operations. This expansion in EVs, which is also reflected in strengthening ties in the wider electronics sector, is underpinned by Asean's move up the manufacturing value chain and the promise of large consumer markets, as the middle class in the region is growing by 5% annually. A similar bright spot is in renewable energy, as Chinese corporates show increasing interest in Asean markets, supported by government efforts across the region in the transition to net zero. DIGITAL PLATFORMS Our survey last year found 31% of respondents saw Asean as a leader in e-commerce and digital platforms. With China having pioneered and then scaled up these technologies, it isn't surprising that Chinese businesses now see growth opportunities in neighbouring Asean as the region seeks to unlock an additional $2 trillion worth of growth by 2030 through the implementation of its Digital Economy Framework Agreement. Notable examples include TikTok's acquisition of 75% of GoTo's e-commerce unit Tokopedia in Indonesia for $840 million, and Alibaba's investment of an additional $630 million into its Singapore e-commerce subsidiary Lazada. The synergies between China and Asean are clear. Over the last few decades, China has achieved leadership positions in many of the sectors that define today's economy, including digital, advanced manufacturing, renewable energy and EVs. Asean's own remarkable growth journey means it is now in a position where it can also manufacture or develop these products and has large-scale demand for them. Opportunity, proximity and these complementary strengths will continue to drive growth in this economic relationship. Giorgio Gamba is the CEO and Krisda Phatcharoen is head of wholesale banking at HSBC Thailand.
OpenAI releases Sora, its buzzy AI video-generation toolThe has rewarded investors with solid gains entering the final month of 2024. As of this writing, the year-to-date gain is 22.32% (26,635.73). All the primary sectors, except communications services, are in positive territory. If the upward trend holds, could beat the 21.74% overall return in 2021. Brian Belski, the chief investment strategist of BMO Capital Markets, sees a stock-picking environment. He maintains a positive outlook, and his year-end 2025 target is 28,500. ( ) and ( ) are among this year’s winning investments. The pair belong to the industrial sector but operate in different industries. Moreover, both trade below $30 and could still skyrocket. Aecon has endured a challenging environment, including cost overruns, in a challenging environment. The $1.8 billion construction and infrastructure development company cater to private and public-sector customers. Two core segments, Construction and Concessions, contribute to revenues. Despite a $73.5 million loss in the first three quarters of 2024, the stock is up 121.35% year to date. At $28 per share, current investors partake in the decent 2.71% dividend. Jean-Louis Servranckx, president and chief executive officer of Aecon, said, “We continue to be focused on embracing opportunities linked to the energy transition and in select U.S. and international markets.” The silver lining is the $6 billion backlog supported by solid demand in recurring revenue programs. According to Servranckx, Aecon is well-positioned to achieve revenue growth commencing in 2025 and over the next few years. The company has a 40% interest in the Flatiron-Aecon Joint Venture, whose contract with the U.S. Army Corps of Engineers is worth US$657 million. Aecon’s nuclear power segment is growing. In late October 2024, management announced a definitive purchase agreement to acquire United Engineers & Constructors for US$33 million. Acquiring the nuclear and conventional power contractor will enhance Aecon’s nuclear capability. Management’s primary goal is to build a resilient company. Given the balanced and diversified work portfolio across sectors, markets, geographies, project types, sizes, and delivery models, the goal is achievable. Aecon expects improved profitability and margin predictability in the coming years. MDA Space is a high flyer in 2024. At $27.69 per share, the year-to-date gain is 140.4%. Had you invested $7,000 a year ago, your money would be $16,869.45 today. The rapidly growing space economy makes the aerospace and defence industry a good investment option. This $3.2 billion company provides advanced space technologies. Its customers include emerging space companies, prime contractors, and government agencies globally. Technological innovation is the primary focus, and MDA aims to contribute to landmark achievements in space through its mission-tested solutions. In the third quarter of 2024, revenue and adjusted net income increased 38% and 59.9% year over year to $282.4 million and $34.7 million, while total backlog rose 49% to $4.6 billion. Its chief executive officer, Mike Greenley, said that as a trusted mission space partner, MDA will leverage its capabilities and expertise to execute targeted growth strategies across end markets and business areas. Aecon and MDA Space are strong buys for long-term or growth investors. Their backlogs provide good revenue visibility for 2025 and beyond. The stock prices should soar alongside revenue growth.
Latest Quinn Ewers Update Possibly Answers Questions About His College Football FutureLife On Mars: As Elon Musk Envisions Colonising Mars, Netizens Start Discussing Who Will Govern
PDP governors meet in Jos ahead NEC meeting
New York, NY, Dec. 26, 2024 (GLOBE NEWSWIRE) -- NorthView Acquisition Corporation (Nasdaq: NVAC) (the “Company”) announced that it has received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that (i) the Staff has determined that the Company’s securities will be delisted from The Nasdaq Stock Market; (ii) trading of the Company’s Common Stock, Rights, and Warrants will be suspended at the opening of business on December 27, 2024; and (iii) a Form 25-NSE will be filed with the Securities and Exchange Commission (the “SEC”), which will remove the Company’s securities from listing on The Nasdaq Stock Market. Pursuant to Nasdaq Listing Rule IM-5101-2, a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement. Since the Company failed to complete its initial business combination by December 20, 2024, the Company did not comply with IM-5101-2, and its securities are now subject to delisting. The Company will not appeal Nasdaq’s determination to delist the Company’s securities and accordingly, the Company’s securities will be suspended from trading on Nasdaq at the opening of business on December 27, 2024. The Company intends to apply for the listing of its securities on the OTC market under the same ticker symbols after they are delisted from Nasdaq. The delisting from Nasdaq does not affect the Company’s previously announced business combination with Profusa Inc., as both parties continue to work to effectuate the closing of the business combination. The merged entity will apply for listing of its securities on the Nasdaq Stock Market in connection with the closing of the business combination. The Company will remain a reporting entity under the Securities Exchange Act of 1934, as amended, with respect to continued disclosure of financial and operational information. About NorthView Acquisition Corporation NorthView Acquisition Corporation is a blank check company incorporated in Delaware for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Forward Looking Statements This press release contains statements that constitute “forward-looking statements”. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and final prospectus for the offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov . The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law. Company Contacts: Fred Knechtel Fredknechtel@hotmail.com (631) 987-8921Pollies, peace deals, and the unravelling of a billionaire: The WA civil court rows that dominated 2024The 49ers' playoff hopes are still teetering even after get-right game against the Bears
Here's what to know about the new funding deal that countries agreed to at UN climate talks(Bloomberg Opinion) -- Disaster. Flop. Average. If you had to bet on a Bollywood movie’s fate in 2024, those would have been your three best options in a year set to end with a 30% to 40% drop in box-office collections. The world’s most prolific film industry is desperately hoping for a better 2025. And so are the city’s cops: When the theaters go empty, the body count starts to rise on the streets of Mumbai. That’s what the 1990s were like — and everyone’s dreading a repeat of lawlessness in India’s financial capital. The fears are far from exaggerated. Baba Siddique, a local politician and real-estate developer who enjoyed close friendships with celebrity actors, was gunned down in October as he was about to get into his car. A member of the gang that claimed responsibility said in a Facebook post that “Bollywood, politics, and property dealings” were behind the murder. Organized crime and the show business of Bombay — as the megalopolis was known until 1995 — have been joined at the hip for a long time. The Golden Age of Indian Cinema that began around the country’s 1947 independence from British rule had a 20-year run. Politics took a cynical turn in the late 1960s, and popular culture began to reflect the loss of idealism. Bollywood scripts shed the social concerns of a young republic and became the escapist fantasy the world knows today. By the early 1970s, India was releasing hundreds of Hindi-language films. Banks wouldn’t finance them. That’s where the likes of Haji Mastan came in. One of Mumbai’s most powerful dons at the time, Mastan was a sucker for glamor. Dressed in all white, the stylish boss became something of a private-equity player for the entertainment business when he began to finance movies for his actress lover. The mob had eked out its initial capital from the docks of Bombay, smuggling gold and electronics. As it reinvented itself for a more open economy in the 1980s and 1990s, bootlegging and extortion gave way to money-laundering, trafficking in drugs and guns ... and more cinema. Dons were no longer satisfied with a profit share, a 2003 report by the Institute of Peace and Conflict Studies noted. They wanted “partnership by becoming producers and getting overseas rights for film and music distribution.” Leading this change was Dawood Ibrahim, a policeman’s son who rose to prominence as the city’s most feared mobster in the post-Mastan era. Dawood began operating from Dubai in the mid-1980s, but his syndicate, known as the D Company, is believed to have carried out the assassination of the founder of T Series, a music-production powerhouse, in 1997. That murder, as well as a subsequent attempt on the life of a producer — whose son Hrithik Roshan was the reigning teen heartthrob — shook the industry. Ibrahim’s suspected involvement in the deadly 1993 terror attack on Mumbai, in which 257 people were killed in a series of bomb blasts across the city, provided urgency to the cleanup. Bollywood has an entire crime noir dedicated to so-called encounter specialists, who would, instead of apprehending underworld operatives and producing them in court, simply execute them. One of my personal favorites is Ab Tak Chhappan, or “56 So Far,” a reference to the kill count. Just when it looked like the city had escaped from that cycle of violence, there are fresh signs of unease. In February 2021, a car packed with explosives was found parked outside the home of Mukesh Ambani, India’s richest tycoon. An elite detective — a former “encounter specialist” — is awaiting trial in that case. While denying the ex-cop’s bail petition last year, a court said his aim was to spread terror in the mind of the Ambani family. Siddique’s murder has deepened the foreboding. Police have invoked a harsh 1999 law designed to crush organized crime. But cops don’t know the underworld’s current level of engagement. “We must have made 20 to 25 films and earned profits, too,” Chhota Shakeel, an Ibrahim aide, had bragged in a 2001 interview, after authorities busted a high-profile case of the mafia’s movie-financing operations. “Instead of extorting money from film personalities, we thought we would do business with them.” Have the proceeds of crime seeped in again, slipping through the veneers of Bollywood’s corporatization? It’s an important law-enforcement question. As the Indian investigative journalist Swati Chaturvedi wrote recently, “Nowhere else in the world does a film industry of this size face such organized threats.” The repercussions go beyond showbiz. Lawrence Bishnoi, the leader of the group suspected of murdering Siddique, has been accused by the Canadian police of colluding with Indian government agents to kill and harass members of the country’s Sikh diaspora. A gangster who’s at the center of a diplomatic spat — and at the same time threatening to eliminate Salman Khan, one of India’s biggest film stars — adds a new dimension to the threat. Arthouse Indian cinema has always felt smothered by kitsch. That has only gotten worse in recent years with right-wing propaganda films competing with the usual song-and-dance and action routines. But now Mumbai is losing control even on its signature over-the-top entertainers. Studios in the southern city of Hyderabad can lay claim to two of the biggest hits in a dull year.(1) That is just like 1984 when the Mumbai industry’s dalliance with crime had begun to get serious. Meanwhile, the acclaimed drama All We Imagine as Light, nominated for two Golden Globes and the winner of this year’s Cannes Grand Prix, is struggling to find exhibitors at home. A second-generation Mumbai producer recently sold half of his studio to Adar Poonawalla, the billionaire vaccine maker who earned handsome profits during Covid-19. The pandemic marked a crucial intermission. It fueled demand for original content people could stream at home on Netflix, Amazon Prime and homegrown apps like Hotstar when cinemas were under lockdown. Now everything is open, and yet audiences are so bored of the insipid fare on screens big and small, they’re neither out for a movie night, nor clicking through big-budget web dramas. When everything starts bombing for Bollywood, things take a sinister turn in Mumbai. More From Bloomberg Opinion: (1) Pushpa: The Rule -- Part 2, made in Telugu and dubbed into five other Indian languages, is an action thriller about a violent sandalwood smuggler. It has beaten Kalki 2898 AD, another Telugu-language movie, as the highest-grossing Indian film of 2024, according to IMDb. This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners. Andy Mukherjee is a Bloomberg Opinion columnist covering industrial companies and financial services in Asia. Previously, he worked for Reuters, the Straits Times and Bloomberg News. More stories like this are available on bloomberg.com/opinion ©2024 Bloomberg L.P.
Highlights of the third quarter include: Revenue of $300.4 million, an increase of 21% compared to $249.2 million in Q3 FY24. Net income of $5.7 million, compared to $14.7 million in Q3 FY24, with non-GAAP net income of $69.4 million, an increase of 33% compared to $52.2 million in Q3 FY24. Net income per diluted share of $0.06, compared to $0.17 in Q3 FY24, with non-GAAP net income per diluted share of $0.78, compared to $0.60 in Q3 FY24. Adjusted EBITDA of $118.2 million, an increase of 24% compared to $95.6 million in Q3 FY24. 9.5 million HSAs, an increase of 15% compared to Q3 FY24. Total HSA Assets of $30.0 billion, an increase of 33% compared to Q3 FY24. 16.5 million Total Accounts, including both HSAs and complementary CDBs, an increase of 8% compared to Q3 FY24. The Company repurchased 0.7 million shares of its common stock for $60.0 million. DRAPER, Utah, Dec. 09, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced financial results for its third quarter ended October 31, 2024. "Strong third quarter results delivered by Team Purple helped drive HSAs to 9.5 million, HSA Assets to $30 billion, Total Accounts to 16.5 million and quarterly revenue to over $300 million, all quarterly records," said Jon Kessler, President and CEO of HealthEquity. "Year to date, we have generated $264 million of cash from operations. This momentum has enabled us to return $60 million of capital to our shareholders via share repurchases, accelerate platform investments, raise our fiscal 2025 guidance, and provide a healthy initial outlook for fiscal year 2026." Third quarter financial results Revenue for the third quarter ended October 31, 2024 was $300.4 million, an increase of 21% compared to $249.2 million for the third quarter ended October 31, 2023. Revenue this quarter included: service revenue of $119.2 million, custodial revenue of $141.0 million, and interchange revenue of $40.3 million. HealthEquity reported net income of $5.7 million, or $0.06 per diluted share, and non-GAAP net income of $69.4 million, or $0.78 per diluted share, for the third quarter ended October 31, 2024. The Company reported net income of $14.7 million, or $0.17 per diluted share, and non-GAAP net income of $52.2 million, or $0.60 per diluted share, for the third quarter ended October 31, 2023. Adjusted EBITDA was $118.2 million for the third quarter ended October 31, 2024, an increase of 24% compared to the third quarter ended October 31, 2023. Adjusted EBITDA was 39% of revenue, compared to 38% for the third quarter ended October 31, 2023. Account and asset metrics HSAs as of October 31, 2024 were 9.5 million, an increase of 15% year over year, including 717,000 HSAs with investments, an increase of 21% year over year. Total Accounts as of October 31, 2024 were 16.5 million, including 7.0 million other consumer-directed benefits ("CDBs"). Total HSA Assets as of October 31, 2024 were $30.0 billion, an increase of 33% year over year. Total HSA Assets included $16.4 billion of HSA cash and $13.6 billion of HSA investments. Client-held funds, which are deposits held on behalf of our Clients to facilitate administration of our CDBs, and from which we generate custodial revenue, were $0.7 billion as of October 31, 2024. Stock repurchase program The Company repurchased 0.7 million shares of its common stock for $60.0 million during the third quarter ended October 31, 2024. As of October 31, 2024, $240.0 million of common stock remained authorized for repurchase under the Company's stock repurchase program. Business outlook For the fiscal year ending January 31, 2025, management expects revenue of $1.185 billion to $1.195 billion. Its outlook for net income is between $88 million and $96 million, resulting in net income of $0.99 to $1.08 per diluted share. Its outlook for non-GAAP net income, calculated using the method described below, is between $274 million and $281 million, resulting in non-GAAP net income per diluted share of $3.08 to $3.16 (based on an estimated 89 million diluted weighted-average shares outstanding). Management expects Adjusted EBITDA of $470 million to $480 million. For the fiscal year ending January 31, 2026, management expects revenue of approximately $1.275 billion to $1.295 billion and Adjusted EBITDA of approximately 41.5% to 42.5% of revenue. These amounts assume an average annualized yield on HSA cash of approximately 3.4% to 3.5%. See “Non-GAAP financial information” below for definitions of our Adjusted EBITDA and non-GAAP net income. A reconciliation of the non-GAAP financial measures used throughout this release (other than with respect to our Adjusted EBITDA outlook for the fiscal year ending January 31, 2026) to the most comparable GAAP financial measures is included with the financial tables at the end of this release. A reconciliation of our Adjusted EBITDA outlook for the fiscal year ending January 31, 2026 to net income, its most directly comparable GAAP measure, is not included, because our net income outlook for this future period is not available without unreasonable efforts as we are unable to predict certain significant items excluded from this non-GAAP measure, such as stock-based compensation expense and income tax provision. Conference call HealthEquity management will host a conference call at 4:30 pm (Eastern Time) on Monday, December 9, 2024 to discuss the fiscal 2025 third quarter financial results. The conference call will be accessible by dialing 1-833-630-1956, or 1-412-317-1837 for international callers, and referencing conference ID "HealthEquity." A live audio webcast of the call will be available on the investor relations section of our website at http://ir.healthequity.com. Non-GAAP financial information To supplement our financial information presented on a GAAP basis, we disclose non-GAAP financial measures, including Adjusted EBITDA, non-GAAP net income, and non-GAAP net income per diluted share. Adjusted EBITDA is earnings before interest, taxes, depreciation and amortization, amortization of acquired intangible assets, stock-based compensation expense, merger integration expenses, acquisition costs, gains and losses on equity securities, amortization of incremental costs to obtain a contract, costs associated with unused office space, and certain other non-operating items. Non-GAAP net income is calculated by adding back to GAAP net income before income taxes the following items: amortization of acquired intangible assets, stock-based compensation expense, merger integration expenses, acquisition costs, gains and losses on equity securities, costs associated with unused office space, and losses on extinguishment of debt, and subtracting a non-GAAP tax provision using a normalized non-GAAP tax rate. Non-GAAP net income per diluted share is calculated by dividing non-GAAP net income by diluted weighted-average shares outstanding. Non-GAAP financial measures should be considered in addition to results prepared in accordance with GAAP and should not be considered as a substitute for, or superior to, GAAP results. We believe that these non-GAAP financial measures provide useful information to management and investors regarding certain financial and business trends relating to the Company's financial condition and results of operations. The Company cautions investors that non-GAAP financial information, by its nature, departs from GAAP; accordingly, its use can make it difficult to compare current results with results from other reporting periods and with the results of other companies. In addition, while amortization of acquired intangible assets is being excluded from non-GAAP net income, the revenue generated from those acquired intangible assets is not excluded. Whenever we use these non-GAAP financial measures, we provide a reconciliation of the applicable non-GAAP financial measure to the most closely applicable GAAP financial measure. Investors are encouraged to review the related GAAP financial measures and the reconciliation of the non-GAAP financial measures to their most directly comparable GAAP financial measure as detailed in the tables below. About HealthEquity HealthEquity and its subsidiaries administer HSAs and various other consumer-directed benefits for over 16 million accounts, working in close partnership with employers, benefits advisors, and health and retirement plan providers who share our unwavering commitment to our mission to save and improve lives by empowering healthcare consumers. Through cutting-edge solutions, innovation, and a relentless focus on improving health outcomes, we empower individuals to take control of their healthcare journey while ultimately enhancing their overall well-being. Learn more about our “Purple" service and approach at www.healthequity.com. Forward-looking statements This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our industry, business strategy, plans, goals and expectations concerning our markets and market position, product expansion, future operations, expenses and other results of operations, revenue, margins, profitability, acquisition synergies, future efficiencies, tax rates, capital expenditures, liquidity and capital resources and other financial and operating information. When used in this discussion, the words “may,” “believes,” “intends,” “seeks,” “aims,” “anticipates,” “plans,” “estimates,” “expects,” “should,” “assumes,” “continues,” “could,” “will,” “future” and the negative of these or similar terms and phrases are intended to identify forward-looking statements in this press release. Forward-looking statements reflect our current expectations regarding future events, results or outcomes. These expectations may or may not be realized. Although we believe the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will prove to be correct. Some of these expectations may be based upon assumptions, data or judgments that prove to be incorrect. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others, risks related to the following: our ability to adequately place and safeguard our custodial assets, or the failure of any of our depository or insurance company partners; our ability to compete effectively in a rapidly evolving healthcare and benefits administration industry; our dependence on the continued availability and benefits of tax-advantaged HSAs and other CDBs; risks relating to our upcoming CEO transition; our ability to successfully identify, acquire and integrate additional portfolio purchases or acquisition targets; the significant competition we face and may face in the future, including from those with greater resources than us; our reliance on the availability and performance of our technology and communications systems; recent and potential future cybersecurity breaches of our technology and communications systems and other data interruptions, including resulting costs and liabilities, reputational damage and loss of business; the current uncertain healthcare environment, including changes in healthcare programs and expenditures and related regulations; our ability to comply with current and future privacy, healthcare, tax, ERISA, investment adviser and other laws applicable to our business; our reliance on partners and third-party vendors for distribution and important services; our ability to develop and implement updated features for our technology platforms and communications systems; and our reliance on our management team and key team members. For a detailed discussion of these and other risk factors, please refer to the risks detailed in our filings with the Securities and Exchange Commission, including, without limitation, our Annual Report on Form 10-K for the fiscal year ended January 31, 2024 and subsequent periodic and current reports. Past performance is not necessarily indicative of future results. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release. Investor Relations Contact Richard Putnam 801-727-1000 rputnam@healthequity.com HealthEquity, Inc. and subsidiaries Condensed consolidated balance sheets HealthEquity, Inc. and subsidiaries Condensed consolidated statements of operations and comprehensive income (unaudited) HealthEquity, Inc. and subsidiaries Condensed consolidated statements of cash flows (unaudited) HealthEquity, Inc. and subsidiaries Condensed consolidated statements of cash flows (unaudited) (continued) Stock-based compensation expense (unaudited) Total stock-based compensation expense included in the condensed consolidated statements of operations and comprehensive income is as follows: Total Accounts (unaudited) * Not meaningful HSA Assets (unaudited) Client-held funds (unaudited) Reconciliation of net income to Adjusted EBITDA (unaudited) Reconciliation of net income outlook to Adjusted EBITDA outlook (unaudited) Reconciliation of net income to non-GAAP net income (unaudited) Reconciliation of net income outlook to non-GAAP net income outlook (unaudited) Certain terms
Israeli police set to probe Netanyahu’s wife over ‘harassment of witnesses’
Wavegate Corporation Logo LAKE CHARLES, La. , Dec. 10, 2024 /PRNewswire/ -- Wavegate Corporation, a pioneering developer of neuromodulation technology for chronic pain management, has secured a lead investor in their $26 million Series A funding round led by UCEA Capital Partners Ltd., a London -based investment firm. This financing will accelerate the development of Wavegate's proprietary Ellipse TM platform, featuring StimuLux TM technology, designed to provide breakthrough therapeutic solutions for chronic pain patients.
The UConn and Louisville women's basketball teams will tip off the 2025-26 season in the Armed Forces Classic at Ramstein Air Base in Germany. Previous editions of the event have been held since 2012, but the Nov. 4, 2025 game announced Thursday will be the first featuring women's hoops. "We want to do as much as we possibly can, both personally and team-wise, to support our armed forces," Huskies head coach Geno Auriemma said in a statement. "I'm glad we're getting the opportunity to go overseas and have many of our military members see us play in person. I know it'll be an experience of a lifetime for everyone in our program." The contest will air on ESPN. "We are extremely thankful to be selected for the 2025 Armed Forces Classic," Louisville coach Jeff Walz said in a statement. "It will be an incredible experience for our players and staff to play in front of some of our nation's heroes overseas. We look forward to the opportunity to showcase women's basketball on an international stage." UConn and Louisville opened the 2024-25 season ranked No. 2 and 17, respectively, in the Associated Press preseason Top 25 poll. Ramstein hosted the Armed Forces Classic in 2012 and 2017. Other locales have included South Korea, Puerto Rico, Japan, Hawaii, Alaska and Texas. --Field Level MediaThe 49ers' playoff hopes are still teetering even after get-right game against the BearsBest sportsbook promo codes for Thursday Night Football: Dec. 26